Blair William & CO Edwards Lifesciences Corp Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Blair William & CO holds 920,776 shares of EW stock, worth $84 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

920,776

Previous 945,681 2.63%

Holding current value

$84 Million

Previous $72.1 Million 22.02%

% of portfolio

0.28%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $1.81 Million - $2.38 Million	-24,905 Reduced 2.63%	920,776 $88 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $3.68 Million - $4.63 Million	-59,594 Reduced 5.93%	945,681 $72.1 Million
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $3.91 Million - $5.27 Million	-56,394 Reduced 5.31%	1,005,275 $69.6 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $2.65 Million - $3.07 Million	32,547 Added 3.16%	1,061,669 $100 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $5.85 Million - $6.66 Million	-78,820 Reduced 7.11%	1,029,122 $85.1 Million

Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $2.3 Million - $2.95 Million	-33,739 Reduced 2.96%	1,107,942 $82.7 Million
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $15,567 - $20,277	189 Added 0.02%	1,141,681 $94.3 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $18.9 Million - $28.1 Million	218,926 Added 23.73%	1,141,492 $109 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $2.34 Million - $2.94 Million	-22,902 Reduced 2.42%	922,566 $109 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.31 Million - $2.83 Million	21,684 Added 2.35%	945,468 $122 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $64,730 - $77,209	-629 Reduced 0.07%	923,784 $105 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $2.37 Million - $2.96 Million	28,241 Added 3.15%	924,413 $95.7 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $210,705 - $242,814	-2,678 Reduced 0.3%	896,172 $75 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $1.18 Million - $1.5 Million	16,425 Added 1.86%	898,850 $82 Million
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $536,243 - $697,858	-7,981 Reduced 0.9%	882,425 $70.4 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $34.2 Million - $45.7 Million	594,194 Added 200.6%	890,406 $61.5 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $443,231 - $685,017	-8,457 Reduced 2.78%	296,212 $55.9 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $103,606 - $118,620	-1,445 Reduced 0.47%	304,669 $71.1 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $70,351 - $86,216	1,143 Added 0.37%	306,114 $67.3 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $701,766 - $810,921	12,590 Added 4.31%	304,971 $56.3 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $433,931 - $580,357	9,061 Added 3.2%	292,381 $55.9 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $152,271 - $186,820	-3,281 Reduced 1.14%	283,320 $43.4 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $331,690 - $421,181	-7,258 Reduced 2.47%	286,601 $49.9 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $2.27 Million - $2.74 Million	-53,403 Reduced 15.38%	293,859 $42.8 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $5.29 Million - $6.74 Million	-142,116 Reduced 29.04%	347,262 $48.5 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $471,809 - $550,002	-13,963 Reduced 2.77%	489,378 $55.2 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $18.3 Million - $19.5 Million	503,341	503,341 $55 Million

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account